People who exhibited ADHD traits at age 10 could be 14 per cent more likely to report two or more physical health issues, such as migraine, back problems, cancer or diabetes by the age of 46, a study ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injury Participants to include people ...
Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug ...
What if the secret to unlocking your most creative self wasn’t about perfecting a single vision, but embracing the unexpected? Below, Future Tech Pilot breaks down the Midjourney Style Creator’s ...
A new study conducted by scientists at the Indian Council of Medical Research (ICMR) has decoded the specific risk factors for breast cancer among women in India. Breast Cancer is among the top three ...
Lack of oil aboard Venezuela tanker seized by US raises eyebrows Army veteran dad of 3 dead after parking spot dispute at Target Fetterman on Greenland: 'Ideally, we purchase it' Safari-style outing ...
Dec 15 (Reuters) - Kyverna Therapeutics (KYTX.O), opens new tab said its experimental cell therapy met the main goal of "significantly" improving patients' ability to walk and reducing muscle ...
Hosted on MSN
Vistagen targets NDA submission for fasedienol in mid-2026 as PALISADE-3 study nears data readout
President and CEO Shawn Singh announced "another major milestone in our PALISADE program. The last patient completed the randomized double-blind portion of our PALISADE-3 Phase III trial, evaluating ...
We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results